依达拉奉治疗急性心肌梗死再灌注损伤的疗效观察
 |
| 第1页 |
参见附件(3343KB，3页)。
[2]Ruiz Gines JA,Lopez Ongil S,Gonzalez Rubio M,et al.React ive oxygen species in duce prolif erat ion of bovine aorticendothelial cells[J].J Cardiovasc Pharmacol,2000,35(1):109.
[3]Fukuda A,Okubo S,Tanabe Y,et al.Card iopro tective effect of edaravone aga inst ischaem iareperfusion in jury in the rabbit heart before, during and a fter reperfusion treatm ent[J].J Int Med Res,2006,34(5):475-484.
[4]Wit AL,Rosen MR.The Heart and Cardiovascular System1[J].New York,NY:Raven Press Publishers,1986,1449-1490.
[5]Wang L,Zhang HY.A theoretical investingation on DPPH radicalscavenging mechanism of edaravone[J].Bioorg Med Chem Lett,2003,13(21):3789-3792.
[6]Katare GR,shiro S,Ryoko S,et al.Antiosdant MC1-186 inhibits mitochondrial pemeablity transitlon pore and upegulates BCL-2 expression[J].AJP-Heart,2003,285(22):2171-2178.
[7]Rajesh KG,Sasaguri S,Suzuki R,et a1.Antioxidant MCl-186inhibits mitochondrial permeability transition pore and upregulates Bcl-2 expression[J].Am J Physial Heart Circ Phys—iol,2003,285(5):2171-2178.
[8]Yano M,Okuda S,Oda T,et a1.Correction of defective interdomaininteraction within ryanodine receptor by antioxidantis a new therapeutic strategy against heart failure[J].Cimulation,2005,112(23):3633-3643.
[9]Tsujita K,Shimonura H,Kawano H,et al.Effects of edaravone on reperfusion injury in patients with acute myocardial infarction[J].Amjcardiol,2004,94(4):481-484.
[10]施益军,陈亦江,吴延虎,等.依达拉奉对心肌缺血再灌注损伤保护作用的临床研究[J].实用临床医药杂志,2006,10(2):50-52.
[11]刘振吉,李永强,赵树芬.依达拉奉对急性心肌梗死静脉溶栓治疗再灌注损伤的影响[J].现代中西医结合杂志,2009,18(8):889-890.
[12]叶维聪,李树裕,苏伟青,等.依达拉奉对急性心肌梗死溶栓后再灌注损伤的影响[J].黑龙江医学,2009,33(11):821-824.
[13]张永明,王禹,刘秀华,等.依达拉奉与缺血后处理对急性心肌缺血再灌注损伤的影响[J].中国康复理论与实践,2008,14(4):110.
[14]崔耀刚,吕小宁.依达拉奉对急性心肌梗死溶栓后再灌注损伤的影响[J].实用临床医药杂志,2011,15(3):71-73.
(收稿日期：2011-05-30)
注：本文中所涉及到的图表、注解、公式等内容请以PDF格式阅读原文
您现在查看是摘要介绍页，详见PDF附件(3343KB，3页)。